Global Information
회사소개 | 문의 | 비교리스트

세계의 C-MET/HGF 저해제 시장(2020년)

Global C-MET HGF Inhibitors Market Research Report 2020

리서치사 QYResearch
발행일 2020년 11월 상품 코드 967953
페이지 정보 영문
가격
US $ 2,900 ₩ 3,251,000 PDF (Single User License)
US $ 4,350 ₩ 4,877,000 PDF (Multi User License)
US $ 5,800 ₩ 6,502,000 PDF (Enterprise Wide License)


세계의 C-MET/HGF 저해제 시장(2020년) Global C-MET HGF Inhibitors Market Research Report 2020
발행일 : 2020년 11월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 C-MET/HGF 저해제 시장 규모는 2019년 15억 6,848만 달러에서 2026년에는 66억 9,861만 달러에 달달하고, 2021-2026년간 연평균 복합 성장률(CAGR)은 24.23%를 나타낼 것으로 예측됩니다.

세계의 C-MET/HGF 저해제(C-MET HGF Inhibitors) 시장에 대해 조사분석했으며, 시장 규모(실적과 예측), 부문별 시장 분석, 주요 기업 등에 대한 정보를 전해드립니다.

목차

제1장 C-MET/HGF 저해제 시장 개요

  • 제품 개요와 범위
  • 부문 : 유형별
  • 부문 : 용도별
  • 세계 시장 규모 추정과 예측

제2장 C-MET/HGF 저해제 시장 경쟁 : 제조업체별

  • 세계의 판매량 점유율 : 제조업체별
  • 세계의 매출 점유율 : 제조업체별
  • 세계의 평균 가격 : 제조업체별
  • 제조업체의 제조거점, 제공 지역, 제품 종류
  • 시장 경쟁 구도와 동향
  • 제조업체의 인수합병(M&A) 및 확장 계획

제3장 C-MET/HGF 저해제 시장 회고 시나리오 : 지역별

  • 세계의 판매량 시나리오 : 지역별
  • 세계의 매출 시나리오 : 지역별
  • 북미 시장 팩트와 수치 : 국가별
  • 유럽 시장 팩트와 수치 : 국가별
  • 아시아태평양 시장 팩트와 수치 : 지역별
  • 남미 시장 팩트와 수치 : 국가별
  • 중동 및 아프리카 시장 팩트와 수치 : 국가별

제4장 C-MET/HGF 저해제 과거 시장 분석 : 유형별

  • 세계의 판매량 점유율 : 유형별
  • 세계의 매출 점유율 : 유형별
  • 세계의 가격 : 유형별

제5장 C-MET/HGF 저해제 과거 시장 분석 : 용도별

  • 세계의 판매량 점유율 : 용도별
  • 세계의 매출 점유율 : 용도별
  • 세계의 가격 : 용도별

제6장 C-MET/HGF 저해제 기업 개요와 주요 수치

  • Exelixis
  • Ipsen
  • Pfizer
  • Novartis
  • Takeda
  • Merck KGaA
  • Merck
  • Daiichi Sankyo
  • GSK
  • Bristol-Myers Squibb
  • Roche
  • AVEO Pharmaceuticals
  • Amgen
  • AstraZeneca
  • Mirati Therapeutics
  • Eli Lilly
  • Johnson & Johnson
  • Eisai
  • Hutchison MediPharma
  • Kringle Pharma

제7장 C-MET/HGF 저해제 제조 비용 분석

  • 주요 원재료 분석
  • 제조 비용 구조
  • 제조 프로세스 분석
  • 업계 체인 분석

제8장 마케팅 채널, 유통업체, 고객

  • 마케팅 채널
  • 유통업체 리스트
  • 고객

제9장 C-MET/HGF 저해제 시장 역학

  • 시장 동향
  • 기회와 촉진요인
  • 시장이 해결해야 할 과제
  • Porter의 산업 분석

제10장 세계 시장 예측

  • 시장 추정과 예측 : 유형별
  • 시장 추정과 예측 : 용도별
  • 시장 추정과 예측 : 지역별

제11장 조사 결과 및 결론

제12장 조사 방법과 데이터 소스

LSH 20.11.16

List of Tables and Figures

  • Table 1. Global C-MET / HGF Inhibitors Sales (K Unit) Growth Rate Comparison by Type (2020-2026)
  • Table 2. Global C-MET / HGF Inhibitors Sales (K Unit) Comparison by Application (2020-2026)
  • Table 3. Global C-MET / HGF Inhibitors Market Size by Region & (US$ Million): 2020 VS 2026
  • Table 4. Key Manufacturers C-MET / HGF Inhibitors Covered in This Study
  • Table 5. Global C-MET / HGF Inhibitors Sales (K Unit) of Key Manufacturers (2019-2020)
  • Table 6. Global C-MET / HGF Inhibitors Sales Market Share by Manufacturers (2019-2020)
  • Table 7. Global C-MET / HGF Inhibitors Revenue (US$ Million) by Manufacturers (2019-2020)
  • Table 8. Global C-MET / HGF Inhibitors Revenue Share by Manufacturers (2019-2020)
  • Table 9. Global Market C-MET / HGF Inhibitors Average Price (USD/Unit) of Key Manufacturers (2019-2020)
  • Table 10. Manufacturers C-MET / HGF Inhibitors Manufacturing Sites and Area Served
  • Table 11. Manufacturers Piplline C-MET / HGF Inhibitors Headquarters
  • Table 12. Manufacturers C-MET / HGF Inhibitors Product Type
  • Table 13. Manufacturers C-MET / HGF Inhibitors on Pipeline
  • Table 14. Global Manufacturers Market Concentration Ratio (CR3 and HHI)
  • Table 15. Global C-MET / HGF Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in C-MET / HGF Inhibitors as of 2019)
  • Table 16. Global C-MET / HGF Inhibitors Sales by Region (2015-2020) & (K Unit)
  • Table 17. Global C-MET / HGF Inhibitors Sales Market Share by Region (2015-2020)
  • Table 18. Global C-MET / HGF Inhibitors Revenue by Region (2015-2020) & (US$ Million)
  • Table 19. North America C-MET / HGF Inhibitors Sales by Country (2015-2020) & (K Unit)
  • Table 20. North America C-MET / HGF Inhibitors Sales Market Share by Country (2015-2020)
  • Table 21. North America C-MET / HGF Inhibitors Revenue by Country (2015-2020) & (US$ Million)
  • Table 22. North America C-MET / HGF Inhibitors Revenue Market Share by Country (2015-2020)
  • Table 23. Europe C-MET / HGF Inhibitors Sales by Country (2015-2020) & (K Unit)
  • Table 24. Europe C-MET / HGF Inhibitors Sales Market Share by Country (2015-2020)
  • Table 25. Europe C-MET / HGF Inhibitors Revenue by Country (2015-2020) & (US$ Million)
  • Table 26. Europe C-MET / HGF Inhibitors Revenue Market Share by Country (2015-2020)
  • Table 27. Asia Pacific C-MET / HGF Inhibitors Sales by Region (2015-2020) & (K Unit)
  • Table 28. Asia Pacific C-MET / HGF Inhibitors Sales Market Share by Region (2015-2020)
  • Table 29. Asia Pacific C-MET / HGF Inhibitors Revenue by Region (2015-2020) & (US$ Million)
  • Table 30. Asia Pacific C-MET / HGF Inhibitors Revenue Market Share by Region (2015-2020)
  • Table 31. South America C-MET / HGF Inhibitors Sales by Country (2015-2020) & (K Unit)
  • Table 32. South America C-MET / HGF Inhibitors Sales Market Share by Country (2015-2020)
  • Table 33. South America C-MET / HGF Inhibitors Revenue by Country (2015-2020) & (US$ Million)
  • Table 34. South America C-MET / HGF Inhibitors Revenue Market Share by Country (2015-2020)
  • Table 35. Middle East and Africa C-MET / HGF Inhibitors Sales by Country (2015-2020) & (K Unit)
  • Table 36. Middle East and Africa C-MET / HGF Inhibitors Sales Market Share by Country (2015-2020)
  • Table 37. Middle East and Africa C-MET / HGF Inhibitors Revenue by Country (2015-2020) & (US$ Million)
  • Table 38. Middle East and Africa C-MET / HGF Inhibitors Revenue Market Share by Country (2015-2020)
  • Table 39. Global C-MET / HGF Inhibitors Sales (K Unit) by Type (2015-2020)
  • Table 40. Global C-MET / HGF Inhibitors Sales Market Share by Type (2015-2020)
  • Table 41. Global C-MET / HGF Inhibitors Revenue (US$ Million) by Type (2015-2020)
  • Table 42. Global C-MET / HGF Inhibitors Revenue Share by Type (2015-2020)
  • Table 43. Global C-MET / HGF Inhibitors Price (USD/Unit) by Type (2015-2020)
  • Table 44. Global C-MET / HGF Inhibitors Sales (K Unit) by Application (2015-2020)
  • Table 45. Global C-MET / HGF Inhibitors Sales Market Share by Application (2015-2020)
  • Table 46. Global C-MET / HGF Inhibitors Revenue (US$ Million) by Application (2015-2020)
  • Table 47. Global C-MET / HGF Inhibitors Revenue Share by Application (2015-2020)
  • Table 48. Global C-MET / HGF Inhibitors Price (USD/Unit) by Application (2015-2020)
  • Table 49. Exelixis Company Profile
  • Table 50. C-MET / HGF Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Exelixis 2019-2020
  • Table 51. Ipsen Company Profile
  • Table 52. C-MET / HGF Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ipsen 2019-2020
  • Table 53. Pfizer Company Profile
  • Table 54. C-MET / HGF Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2019-2020
  • Table 55. Novartis Company Profile
  • Table 56. C-MET / HGF Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2019-2020
  • Table 57. Takeda Company Profile
  • Table 58. C-MET / HGF Inhibitors Product Introduction of Takeda
  • Table 59. C-MET / HGF Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Takeda 2019-2020
  • Table 60. Merck KGaA Company Profile
  • Table 61. C-MET / HGF Inhibitors Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck KGaA 2019-2020
  • Table 62. Merck Company Profile
  • Table 63. C-MET / HGF Inhibitors Product Introduction of Merck
  • Table 64. Daiichi Sankyo Company Profile
  • Table 65. C-MET / HGF Inhibitors Product Introduction of Daiichi Sankyo
  • Table 66. GSK Company Profile
  • Table 67. C-MET / HGF Inhibitors Product Introduction of GSK
  • Table 68. Bristol-Myers Squibb Company Profile
  • Table 69. C-MET / HGF Inhibitors Product Introduction of Bristol-Myers Squibb
  • Table 70. Roche Company Profile
  • Table 71. C-MET / HGF Inhibitors Product Introduction of Roche
  • Table 72. AVEO Pharmaceuticals Company Profile
  • Table 73. C-MET / HGF Inhibitors Product Introduction of AVEO Pharmaceuticals
  • Table 74. Amgen Company Profile
  • Table 75. C-MET / HGF Inhibitors Product Introduction of Amgen
  • Table 76. AstraZeneca Company Profile
  • Table 77. C-MET / HGF Inhibitors Product Introduction of AstraZeneca
  • Table 78. Mirati Therapeutics Company Profile
  • Table 79. C-MET / HGF Inhibitors Product Introduction of Mirati Therapeutics
  • Table 80. Eli Lilly Company Profile
  • Table 81. C-MET / HGF Inhibitors Product Introduction of Eli Lilly
  • Table 82. Johnson & Johnson Company Profile
  • Table 83. C-MET / HGF Inhibitors Product Introduction of Johnson & Johnson
  • Table 84. Eisai Company Profile
  • Table 85. Hutchison MediPharma Company Profile
  • Table 86. C-MET / HGF Inhibitors Product Introduction of Hutchison MediPharma
  • Table 87. Kringle Pharma Company Profile
  • Table 88. Out-of-pocket Preclinical and Clinical Period Cost Per Investigational Drugs Compound
  • Table 89. Capitalized Preclinical and Clinical Period costs per Investigational Drugs Compound
  • Table 90. C-MET / HGF Inhibitors Distributors List
  • Table 91. C-MET / HGF Inhibitors Customers List
  • Table 92. C-MET / HGF Inhibitors Market Trends
  • Table 93. C-MET / HGF Inhibitors Opportunities and Drivers
  • Table 94. C-MET / HGF Inhibitors Market Challenges
  • Table 95. Global C-MET / HGF Inhibitors Sales Forecast by Type (2021-2026) & (K Unit)
  • Table 96. Global C-MET / HGF Inhibitors Sales Market Share Forecast by Type (2021-2026)
  • Table 97. Global C-MET / HGF Inhibitors Revenue Forecast by Type (2021-2026) & (US$ Million)
  • Table 98. Global C-MET / HGF Inhibitors Revenue Market Share Forecast by Type (2021-2026)
  • Table 99. Global C-MET / HGF Inhibitors Sales Forecast by Application (2021-2026) & (K Unit)
  • Table 100. Global C-MET / HGF Inhibitors Sales Market Share Forecast by Application (2021-2026)
  • Table 101. Global C-MET / HGF Inhibitors Revenue Forecast by Application (2021-2026) & (US$ Million)
  • Table 102. Global C-MET / HGF Inhibitors Revenue Market Share Forecast by Application (2021-2026)
  • Table 103. Global C-MET / HGF Inhibitors Sales Forecast by Region (2021-2026) & (K Unit)
  • Table 104. Global C-MET / HGF Inhibitors Sales Market Share Forecast by Region (2021-2026)
  • Table 105. Global C-MET / HGF Inhibitors Revenue Forecast by Region (2021-2026) & (US$ Million)
  • Table 106. Global C-MET / HGF Inhibitors Revenue Market Share Forecast by Region (2021-2026)
  • Table 107. Research Programs/Design for This Report
  • Table 108. Key Data Information from Secondary Sources
  • Table 109. Key Data Information from Primary Sources
  • Figure 1. Product Picture of C-MET / HGF Inhibitors
  • Figure 2. Global C-MET / HGF Inhibitors Market Share by Type in 2020
  • Figure 3. Global C-MET / HGF Inhibitors Market Share by Type in 2026
  • Figure 4. Cabozantinib Product Picture
  • Figure 5. Crizotinib Product Picture
  • Figure 6. Global C-MET / HGF Inhibitors Market Share by Application in 2020
  • Figure 7. Global C-MET / HGF Inhibitors Market Share by Application in 2026
  • Figure 8. Hospital
  • Figure 9. Drug Store
  • Figure 10. Global C-MET / HGF Inhibitors Revenue (US$ Million), 2015 VS 2020 VS 2026
  • Figure 11. Global C-MET / HGF Inhibitors Revenue 2015-2026 (US$ Million)
  • Figure 12. Global C-MET / HGF Inhibitors Sales 2015-2026 (K Unit)
  • Figure 13. Global C-MET / HGF Inhibitors Market Size by Region: 2020 Versus 2026
  • Figure 14. C-MET / HGF Inhibitors Sales Share by Manufacturers in 2019
  • Figure 15. Global C-MET / HGF Inhibitors Revenue Share by Manufacturers in 2019
  • Figure 16. Figure Global 3 Largest C-MET / HGF Inhibitors Players: Market Share by Revenue in C-MET / HGF Inhibitors in 2019
  • Figure 17. Global C-MET / HGF Inhibitors Sales Market Share by Region in 2019
  • Figure 18. Global C-MET / HGF Inhibitors Revenue Market Share by Region in 2019
  • Figure 19. North America C-MET / HGF Inhibitors Sales Market Share by Country in 2019
  • Figure 20. North America C-MET / HGF Inhibitors Revenue Market Share by Country in 2019
  • Figure 21. United States C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 22. Canada C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 23. Mexico C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 24. Europe C-MET / HGF Inhibitors Revenue Market Share by Country in 2019
  • Figure 25. Germany C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 26. France C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 27. U.K. C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 28. Italy C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 29. Russia C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 30. Asia Pacific C-MET / HGF Inhibitors Revenue Market Share by Region in 2019
  • Figure 31. China C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 32. Japan C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 33. South Korea C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 34. India C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 35. Australia C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 36. Southeast Asia C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 37. Brazil C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 38. Middle East C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 39. Africa C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) & (US$ Million)
  • Figure 40. Sales Market Share of C-MET / HGF Inhibitors by Type in 2019
  • Figure 41. Revenue Market Share of C-MET / HGF Inhibitors by Type in 2019
  • Figure 42. Sales Market Share of C-MET / HGF Inhibitors by Application in 2019
  • Figure 43. Revenue Market Share of C-MET / HGF Inhibitors by Application in 2019
  • Figure 44. C-MET / HGF Inhibitors Product Introduction of Exelixis
  • Figure 45. C-MET / HGF Inhibitors Product Introduction of Ipsen
  • Figure 46. C-MET / HGF Inhibitors Product Introduction of Pfizer
  • Figure 47. C-MET / HGF Inhibitors Product Introduction of Novartis
  • Figure 48. C-MET / HGF Inhibitors Product Introduction of Merck KGaA
  • Figure 49. C-MET / HGF Inhibitors Product Introduction of Eisai
  • Figure 50. typical phases from research to the market for a drug candidate
  • Figure 51. Manufacturing Cost Structure of C-MET / HGF Inhibitors
  • Figure 52. Manufacturing Process Analysis of C-MET / HGF Inhibitors
  • Figure 53. C-MET / HGF Inhibitors Industrial Chain Analysis
  • Figure 54. Channels of Distribution
  • Figure 55. Distributors Profiles
  • Figure 56. Porter's Five Forces Analysis
  • Figure 57. Bottom-up and Top-down Approaches for This Report
  • Figure 58. Data Triangulation
  • Figure 59. Key Executives Interviewed 106

In 2019, the global C-MET / HGF Inhibitors market size was increased to US$ 1568.48 million from US$ 522.16 million in 2015, and it will reach US$ 6698.61 million in 2026, growing at CAGR of 24.23% between 2021 and 2026.

This report focuses on C-MET / HGF Inhibitors volume and value at the global level, regional level and company level. From a global perspective, this report represents overall C-MET / HGF Inhibitors market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, etc.

Global C-MET / HGF Inhibitors Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company

  • Exelixis
  • Ipsen
  • Pfizer
  • Novartis
  • Takeda
  • Merck KGaA
  • Merck
  • Daiichi Sankyo
  • GSK
  • Bristol-Myers Squibb(BMS)
  • Roche
  • AVEO Pharmaceuticals
  • Amgen
  • AstraZeneca
  • Mirati Therapeutics
  • Eli Lilly
  • Johnson & Johnson
  • Eisai
  • Hutchison MediPharma
  • Kringle Pharmaceuticals

Segment by Type

  • Cabozantinib
  • Crizotinib
  • Other

Segment by Application

  • Hospital
  • Drug Store

By Region

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Southeast Asia
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Latin America
  • Brazil
  • Middle East & Africa
  • Middle East
  • Africa

TABLE OF CONTENTS

1 C-MET / HGF INHIBITORS MARKET OVERVIEW

  • 1.1 Product Overview and Scope of C-MET / HGF Inhibitors
  • 1.2 C-MET / HGF Inhibitors Segment by Type
    • 1.2.1 Global C-MET / HGF Inhibitors Sales Growth Rate Comparison by Type (2020-2026)
    • 1.2.2 Cabozantinib
    • 1.2.3 Crizotinib
  • 1.3 C-MET / HGF Inhibitors Segment by Application
    • 1.3.1 Global C-MET / HGF Inhibitors Sales Comparison by Application (2020-2026)
    • 1.3.2 Hospital
    • 1.3.3 Drug Store
  • 1.4 Global C-MET / HGF Inhibitors Market Size Estimates and Forecasts
    • 1.4.1 Global C-MET / HGF Inhibitors Revenue 2015-2026
    • 1.4.2 Global C-MET / HGF Inhibitors Sales 2015-2026
    • 1.4.3 C-MET / HGF Inhibitors Market Size by Region: 2020 Versus 2026

2 GLOBAL C-MET / HGF INHIBITORS MARKET COMPETITION BY MANUFACTURERS

  • 2.1 Global C-MET / HGF Inhibitors Sales Market Share by Manufacturers (2019-2020)
  • 2.2 Global C-MET / HGF Inhibitors Revenue Market Share by Manufacturers (2019-2020)
  • 2.3 Global C-MET / HGF Inhibitors Average Price by Manufacturers (2019-2020)
  • 2.4 Manufacturers C-MET / HGF Inhibitors Manufacturing Sites, Area Served, Product Type
  • 2.5 C-MET / HGF Inhibitors Market Competitive Situation and Trends
    • 2.5.1 C-MET / HGF Inhibitors Market Concentration Rate
    • 2.5.2 The Global 3 Largest C-MET / HGF Inhibitors Players Market Share by Revenue
    • 2.5.3 Global C-MET / HGF Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 C-MET / HGF INHIBITORS RETROSPECTIVE MARKET SCENARIO BY REGION

  • 3.1 Global C-MET / HGF Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global C-MET / HGF Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America C-MET / HGF Inhibitors Market Facts & Figures by Country
    • 3.3.1 North America C-MET / HGF Inhibitors Sales by Country
    • 3.3.2 North America C-MET / HGF Inhibitors Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
    • 3.3.5 Mexico
  • 3.4 Europe C-MET / HGF Inhibitors Market Facts & Figures by Country
    • 3.4.1 Europe C-MET / HGF Inhibitors Sales by Country
    • 3.4.2 Europe C-MET / HGF Inhibitors Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific C-MET / HGF Inhibitors Market Facts & Figures by Region
    • 3.5.1 Asia Pacific C-MET / HGF Inhibitors Sales by Region
    • 3.5.2 Asia Pacific C-MET / HGF Inhibitors Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Southeast Asia
  • 3.6 South America C-MET / HGF Inhibitors Market Facts & Figures by Country
    • 3.6.1 South America C-MET / HGF Inhibitors Sales by Country
    • 3.6.2 South America C-MET / HGF Inhibitors Revenue by Country
    • 3.6.3 Brazil
  • 3.7 Middle East and Africa C-MET / HGF Inhibitors Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa C-MET / HGF Inhibitors Sales by Country
    • 3.7.2 Middle East and Africa C-MET / HGF Inhibitors Revenue by Country
    • 3.7.3 Middle East
    • 3.7.4 Africa

4 GLOBAL C-MET / HGF INHIBITORS HISTORIC MARKET ANALYSIS BY TYPE

  • 4.1 Global C-MET / HGF Inhibitors Sales Market Share by Type (2015-2020)
  • 4.2 Global C-MET / HGF Inhibitors Revenue Market Share by Type (2015-2020)
  • 4.3 Global C-MET / HGF Inhibitors Price by Type (2015-2020)

5 GLOBAL C-MET / HGF INHIBITORS HISTORIC MARKET ANALYSIS BY APPLICATION

  • 5.1 Global C-MET / HGF Inhibitors Sales Market Share by Application (2015-2020)
  • 5.2 Global C-MET / HGF Inhibitors Revenue Market Share by Application (2015-2020)
  • 5.3 Global C-MET / HGF Inhibitors Price by Application (2015-2020)

6 COMPANY PROFILES AND KEY FIGURES IN C-MET / HGF INHIBITORS BUSINESS

  • 6.1 Exelixis
    • 6.1.1 Company Profile
    • 6.1.2 Product Information
    • 6.1.3 Sales, Price, Gross Margin and Revenue
  • 6.2 Ipsen
    • 6.2.1 Company Profile
    • 6.2.2 Product Information
    • 6.2.3 Sales, Price, Gross Margin and Revenue
  • 6.3 Pfizer
    • 6.3.1 Company Profile
    • 6.3.2 Product Information
    • 6.3.3 Sales, Price, Gross Margin and Revenue
  • 6.4 Novartis
    • 6.4.1 Company Profile
    • 6.4.2 Product Information
    • 6.4.3 Sales, Price, Gross Margin and Revenue
  • 6.5 Takeda
    • 6.5.1 Company Profile
    • 6.5.2 Product Information
    • 6.5.3 Sales, Price, Gross Margin and Revenue
  • 6.6 Merck KGaA
    • 6.6.1 Company Profile
    • 6.6.2 Product Information
    • 6.6.3 Sales, Price, Gross Margin and Revenue
  • 6.7 Merck
    • 6.7.1 Company Profile
    • 6.7.2 Product Information
  • 6.8 Daiichi Sankyo
    • 6.8.1 Company Profile
    • 6.8.2 Product Information
  • 6.9 GSK
    • 6.9.1 Company Profile
    • 6.9.2 Product Information
  • 6.10 Bristol-Myers Squibb
    • 6.10.1 Company Profile
    • 6.10.2 Product Information
  • 6.11 Roche
    • 6.11.1 Company Profile
    • 6.11.2 Product Information
  • 6.12 AVEO Pharmaceuticals
    • 6.12.1 Company Profile
    • 6.12.2 Product Information
  • 6.13 Amgen
    • 6.13.1 Company Profile
    • 6.13.2 Product Information
  • 6.14 AstraZeneca
    • 6.14.1 Company Profile
    • 6.14.2 Product Information
  • 6.15 Mirati Therapeutics
    • 6.15.1 Company Profile
    • 6.15.2 Product Information
  • 6.16 Eli Lilly
    • 6.16.1 Company Profile
    • 6.16.2 Product Information
  • 6.17 Johnson & Johnson
    • 6.17.1 Company Profile
    • 6.17.2 Product Information
  • 6.18 Eisai
    • 6.18.1 Company Profile
    • 6.18.2 Product Information
  • 6.19 Hutchison MediPharma
    • 6.19.1 Company Profile
    • 6.19.2 Product Information
  • 6.20 Kringle Pharma

7 C-MET / HGF INHIBITORS MANUFACTURING COST ANALYSIS

  • 7.1 C-MET / HGF Inhibitors R&D Cost Analysis
    • 7.1.1 Clinical Phase Costs
    • 7.1.2 Capitalized Costs
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of C-MET / HGF Inhibitors
  • 7.4 C-MET / HGF Inhibitors Industrial Chain Analysis

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

  • 8.1 Marketing Channel
  • 8.2 C-MET / HGF Inhibitors Distributors List
  • 8.3 C-MET / HGF Inhibitors Customers

9 C-MET / HGF INHIBITORS MARKET DYNAMICS

  • 9.1 C-MET / HGF Inhibitors Market Trends
  • 9.2 C-MET / HGF Inhibitors Opportunities and Drivers
  • 9.3 C-MET / HGF Inhibitors Market Challenges
  • 9.4 Porter's Five Forces Analysis

10 GLOBAL MARKET FORECAST

  • 10.1 C-MET / HGF Inhibitors Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of C-MET / HGF Inhibitors by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of C-MET / HGF Inhibitors by Type (2021-2026)
  • 10.2 C-MET / HGF Inhibitors Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of C-MET / HGF Inhibitors by Application (2021-2026)
    • 10.2.2 Global Forecasted Revenue of C-MET / HGF Inhibitors by Application (2021-2026)
  • 10.3 C-MET / HGF Inhibitors Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of C-MET / HGF Inhibitors by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of C-MET / HGF Inhibitors by Region (2021-2026)

11 RESEARCH FINDINGS AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

  • 12.1 Methodology/Research Approach
    • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
  • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
  • 12.3 Author List
  • 12.4 Disclaimer
Back to Top
전화 문의
F A Q